ACRO Biomedical Co., Ltd.
TWO: 6748.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Dar-Jen Hsieh
- Employees
- 42
- Headquarters
- Kaohsiung City, Taiwan
- IPO year
- 2021
- Market cap
- NT$5.1B
- Website
- http://www.acrobiomedical.com
Loading 6748…
Loading profile data…Frequently asked questions about 6748
What does ACRO Biomedical Co., Ltd. (6748.TWO) do?
ACRO Biomedical Co., Ltd. develops and produces biomaterial medical devices for human tissue engineering and regenerative medicine. The company was founded on June 26, 2014 and is headquartered in Kaoshiung, Taiwan.
Where does 6748.TWO trade?
ACRO Biomedical Co., Ltd. (6748.TWO) trades on the Taipei Exchange.
What sector is 6748.TWO in?
ACRO Biomedical Co., Ltd. (6748.TWO) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of ACRO Biomedical Co., Ltd.?
Dar-Jen Hsieh is the chief executive officer of ACRO Biomedical Co., Ltd. (6748.TWO).
Where is ACRO Biomedical Co., Ltd. headquartered?
ACRO Biomedical Co., Ltd. is headquartered in Taiwan.
Does 6748.TWO pay a dividend?
ACRO Biomedical Co., Ltd. (6748.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6748.TWO go public?
ACRO Biomedical Co., Ltd. (6748.TWO) completed its initial public offering in 2021.